Gammaherpesviruses entry and early events during infection

Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis

Volumn , Issue , 2007, Pages 360-378

  Chandran, Bala ^a   Hutt Fletcher, Lindsey ^b  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79960792025     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511545313.024     Document Type: Chapter

References (142)

1. Akula, S. M., Pramod, N. P., Wang, F. Z., and Chandran, B. (2001a). Human herpesvirus 8 envelope-associated glycoprotein B interacts with heparan sulfate-like moieties. Virology, 284(2), 235-249.
2. Akula, S. M., Wang, F. Z., Vieira, J., and Chandran, B. (2001b). Human herpesvirus 8 interaction with target cells involves heparan sulfate. Virology, 282(2), 245-255.
3. Akula, S. M., Pramod, N. P., Wang, F. Z., and Chandran, B. (2002). Integrin a3b1 (CD49c/29) is a cellular receptor for Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8) entry into tar-get cells. Cell, 108, 407-419.
4. Akula, S. M., Naranatt, P. P., Walia, N. S., Wang, F. Z., Fegley, B., and Chandran, B. (2003). Kaposi's sarcoma-associated her-pesvirus (human herpesvirus 8) infection of human ?broblast cells occurs through endocytosis. J. Virol., 77(14), 7978-7990.
5. Anagnostopoulos, I., Hummel, M., Kreschel, C., and Stein, H. (1995). Morphology, immunophenotype and distribution of latently and/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: Implications for the interindividual individual infection route of Epstein-Barr virus. Blood, 5, 744-750.
6. Antman, K. and Chang, Y. (2000). Kaposi's sarcoma. N. Engl. J. Med., 342(14), 1027-1038.
7. Baer, R., Bankier, A. T., Biggin, M. D. et al. (1984). DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature, 310, 207-211.
8. Baghian, A., Luftig, M., Black, J. B. et al. (2000). Glycoprotein B of human herpesvirus 8 is a component of the virion ina cleaved form composed of amino-and carboxyl-terminal fragments. Virology, 269(1), 18-25.
9. Ballestas, M. E., Chatis, P. A., and Kaye, K. M. (1999). Ef?cient persis-tence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science, 282, 641-644.
10. Bayliss, G. J. and Wolf, H. (1980). Epstein-Barr virus induced cell fusion. Nature, 287, 164-165.
11. Bechtel, J. T., Liang, Y., Hvidding, J., and Ganem, D. (2003). Host range of Kaposi's sarcoma-associated herpesvirus in cultured cells. J. Virol., 77(11), 6474-6481.
12. Beisel, C., Tanner, J., Matsuo, T. et al. (1985). Two major outer enve-lope glycoproteins of Epstein-Barr virus are encoded by the same gene. J. Virol., 54, 665-674.
13. Beisser, P. S., Versijl, D., Gruijthuijsen, Y. K. et al. (2005). The Epstein-Barr virus BILF1 gene encodes a G protein-coupled recep-tor that inhibits phosphorylation of RNA-dependent protein kinase. J. Virol., 79, 441-449.
14. Birkmann, A., Mahr, K., Ensser, A. et al. (2001). Cell surface heparan sulfate is a receptor for human herpesvirus 8 and interacts with envelope glycoprotein K8.1. J. Virol., 75(23), 11583-11593.
15. Blackbourn, D. J., Lennette, E., Klencke, B. et al. (2000). The restricted cellular host range of human herpesvirus 8. AIDS, 14(9), 1123-1133.
16. Borza, C. and Hutt-Fletcher, L.M.(1998). Epstein-Barr virus recom-binant lacking expression of glycoprotein gp150 infects B cells normally but is enhanced for infection of the epithelial line SVKCR2. J. Virol., 72, 7577-7582.
17. Borza, C. M. and Hutt-Fletcher, L. M. (2002). Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus. Nature Med., 8, 594-599.
18. Borza, C. M., Morgan, A. J., Turk, S. M., and Hutt-Fletcher, L. M. (2004). Use of gHgL for attachment of Epstein-Barr virus to epithelial cells compromises infection. J. Virol., 78, 5007-5014.
19. Calderwood, D. A., Shattil, S. J., and Ginsberg, M. H.(2000). Integrins and actin ?laments: Reciprocal regulation of cell adhesion and signaling. J. Biol. Chem., 275(30), 22607-22610.
20. Chandran, B., Bloomer, C., Chan, S. R., Zhu, L., Goldstein, E., and Horvat, R. (1998). Human herpesvirus-8 ORF K8.1 gene encodes immunogenic glycoproteins generated by spliced transcripts. Virology, 249(1), 140-149.
21. Ciufo, D. M., Cannon, J. S., Poole, L. J. et al. (2001). Spindle cell con-version by Kaposi's sarcoma-associated herpesvirus: Forma-tion of colonies and plaques with mixed lytic and latent gene expressionininfectedprimarydermalmicrovascular endothe-lial cell cultures. J. Virol., 75(12), 5614-5626.
22. Colman, P. M. and Lawrence, M. C. (2003). The structural biology of type 1 viral membrane fusion. Nat. Rev. Mol. Cell Biol., 4, 309-319.
23. Daddario, M. D., Libermann, T. A., Xu, J., Ahmad, A., and Menezes, J. (2001). Epstein-Barr virus and its glycoprotein-350 upreg-ulate IL-6 in human B-lymphocytes via CD21, involving activation of NF-kB and different signaling pathways. J. Mol. Biol., 308, 501-504.
24. Dezube, B. J., Zambela, M., Sage, D. R., Wang, J. F., and Fin-geroth, J. D. (2002). Characterization of Kaposi sarcoma-associated herpesvirus/human herpesvirus-8 infection of human vascular endothelial cells: Early events. Blood, 100(3), 888-896.
25. Dourmishev, L. A., Dourmishev, A. L., Palmeri, D., Schwartz, R. A., and Lukac, D. M. (2003). Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epi-demiology and pathogenesis. Microbiol. Mol. Biol. Rev., 67(2), 175-212.
26. Farina, A., Santarello, R., Gonnella, R. et al. (2000). The BFRF1 gene of Epstein-Barr virus encodes a novel protein. J. Virol., 74, 3235-3244.
27. Farina, A., Cardinale, G., Santarella, R. et al. (2004). Intracellular localization of the Epstein-Barr virus BFRF1 gene product in lymphoid cell lines and oral hairy leukoplakis lesions. J. Med. Virol., 72, 102-111.
28. Farina, A., Feederle, R., Raffa, S. et al. (2005). BFRF1 of Epstein-Barr virus is essential fro ef?cient primary envelopment and egress. J. Virol., 79, 3703-3712.
29. Feral, C. C., Nishiya, N., Fenczik, C. A., Stuhlmann, H., Slepak, M., and Ginsberg, M. H. (2005). CD98hc (SLC3A2) mediates inte-grin signaling. Proc. Natl Acad. Sci. USA, 102, 355-360.
30. Fenczik, C. A., Zent, R., Dellos, M. et al. (2001). Distinct domains of CD98hc regulate integrins and amino acid transport. J. Biol. Chem., 276, 8746-8752.
31. Fingeroth, J. D., Weis, J. J., Tedder, T. F., Strominger, J. L., Biro, P. A., and Fearon, D. T. (1984). Epstein-Barr virus receptor of human B lymphocytes is the C3d complement CR2. Proc. Natl Acad. Sci. USA, 81, 4510-4516.
32. Fingeroth, J. D., Diamond, M. E., Sage, D. R., Hayman, J., and Yates, J. L.(1999). CD-21 dependent infection of an epithelial cell line, 293, by Epstein-Barr virus. J. Virol., 73, 2115-2125.
33. Frade, R., Barel, M., Ehlin-Henricksson, B., and Klein, G. (1985). gp140 the C3d receptor of human B lymphocytes is also the Epstein-Barr virus receptor. Proc. NatlAcad. Sci. USA, 82,1490-1493.
34. Frangou, P., Buettner, M., and Niedobitek, G. (2005). Epstein-Barr virus (EBV) infection in epithelial cells in vivo; rare detection of EBV replication in tongue mucosa but not in salivary glands. J. Infect. Dis., 191, 238-242.
35. Gan, Y., Chodosh, J., Morgan, A., and Sixbey, J. W. (1997). Epithelial cell polarization is a determinant in the infectious outcome of immunoglobulin A-mediated entry by Epstein-Barr virus. J. Virol., 71, 519-526.
36. Ganem, D. (1998). Human herpesvirus 8 and its role in the gene-sis of Kaposi's sarcoma. Curr. Clin. Top. Infect. Dis., 18, 237-251.
37. Giancotti, F. G. (2000). Complexity and speci?city of integrin signalling. Nat. Cell Biol., 2(1), E13-E14.
38. Giancotti, F. G. and Ruoslahti, E. (1999). Integrin signaling. Science, 285(5430), 1028-1032.
39. Gong, M. and Kieff, E. (1990). Intracellular traf?cking of two major Epstein-Barr virus glycoproteins, gp350/220 and gp110. J. Virol., 64, 1507-1516.
40. Gong, M., Ooka, T., Matsuo, T., and Kieff, E. (1987). Epstein-Barr virus glycoprotein homologous to herpes simplex virus gB. J. Virol., 61, 499-508.
41. Gonnella, R., Farina, A., Santarella, R. et al. (2005). Characterization and intracellular localization of the Epstein-Barr virus protein BFLF2: Interactions with BFRF1 and with the nuclear lamina. J. Virol., 49, 3713-3237.
42. Gordon, J. S., Walker, L., Guy, G., Brown, G., Rowe, M., and Rick-inson, A. (1986). Control of human B-lymphocyte transforma-tion. II. Transforming Epstein-Barr virus exploits three distinct viral signals to undermine three separate control points in B cell growth. Immunology, 58, 591-595.
43. Grundhoff, A. and Ganem, D. (2004). Inef?cient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. J. Clin. Invest., 113, 124-136.
44. Haan, K. M. and Longnecker, R. (2000). Coreceptor restriction within the HLA-DQ locusfor Epstein-Barr virus infection. Proc. Natl Acad. Sci. USA, 97, 9252-9257.
45. Haan, K. M., Lee, S. K., and Longnecker, R. (2001). Different func-tional domains in the cytoplasmic tail of glycoprotein gB are involved in Epstein-Barr virus induced membrane fusion. Virology, 290, 106-114.
46. Haddad, R. S. and Hutt-Fletcher, L. M. (1989). Depletion of glyco-protein gp85 from virosomes made with Epstein-Barr virus proteins abolishes their ability to fuse with virus receptor-bearing cells. J. Virol., 63, 4998-5005.
47. Hall, A. and Nobes, C. D. (2000). Rho GTPases: Molecular switches that control the organization and dynamics of the actin cytoskeleton. Phil. Trans. R. Soc. Lond. B Biol. Sci., 355(1399), 965-970.
48. Heineman, T., Gong, M., Sample, J., and Kieff, E. (1988). Identi?-cation of the Epstein-Barr virus gp85 gene. J. Virol., 62, 1101-1107.
49. Huber, M. T. and Compton, T. (1998). The human cytomegalovirus UL74 gene encodes the third component of the glycoprotein H-glycoprotein L-containing envelope complex. J. Virol., 72, 8191-8197.
50. Hummel, M. and Kieff, E. (1982). Epstein-Barr virus RNA. VIII. Viral RNA in permissively infected B95-8 cells. J. Virol., 43, 262-272.
51. Hummel, M., Thorley-Lawson, D., and Kieff, E. (1984). An Epstein-Barr virus DNA fragment encodes messages for the two major envelope glycoproteins (gp350/300 and gp220/200). J. Virol., 49, 413-417.
52. Hurley, E. A. and Thorley-Lawson, D. A. (1988). B cell activation and the establishment of Epstein-Barr virus latency. J. Exp. Med., 168, 2059-2075.
53. Hutt-Fletcher, L. M. (2002). Epstein-Barr virus glycoproteins and their roles in virus entry and egress. In Structure-function Rela-tionships of Human Pathogenic Viruses, ed. A. Holzenburg and E. Bogner. New York: Kluwer Academic/Plenum.
54. Imai, S., Nishikawa, J., and Takada, K. (1998). Cell-to-cell contact as an ef?cient mode of Epstein-Barr virus infection of diverse human epithelial cells. J. Virol., 72, 4371-4378.
55. Inoue, N., Winter, J., Lal, R. B., Offermann, M. K., and Koyano, S. (2003). Characterization of entry mechanisms of human her-pesvirus 8 byusing an Rta-dependent reporter cell line. J. Virol., 77, 8143-8152.
56. Jiang, R., Scott, R. S., and Hutt-Fletcher, L. M. (2006). Epstein-Barr virus shed in saliva is high in B cell tropic gp42. J. Virol., 80, 7281-7283.
57. Johannsen, E., Luftig, M., Weicksel, S. et al. (2004). Proteins of puri-?ed Epstein-Barr virus. Proc. Natl Acade. Sci. USA, 101, 16286-16291.
58. Kaleeba, J. A. R and Berger, E. A. (2006). Kaposi's Sarcoma-associated herpesvirus fusion-entry receptor: Cystine trans-porter xCT. Science, 311, 1921-1924.
59. Kieff, E. and Rickinson, A. B. (2001). Epstein-Barr virus and its repli-cation. In Fields Virology ed. D. M. Knipe, and P. M. Howley, Vol. 2, pp. 2511-2573.2 vols. Philadelphia: Lippincott Williams and Wilkins.
60. Klupp, B. and Mettenleiter, T. C. (1991). Sequence and expression of the glycoprotein gH gene of pseudorabies virus. Virology, 182, 732-741.
61. Koyano, S., Mar, E. C., Stamey, F. R., and Inoue, N. (2003). Glyco-proteinsM and N of human herpesvirus 8 form a complex and inhibit cell fusion. J. Gen. Virol., 84, 1485-1491.
62. Krishnan, H. H., Walia, N. S., Streblow, D. N., Naranatt, P. P., and Chandran, B. (2006). Focal adhesion kinase (FAK) is critical for Kaposi's Sarcoma-associated herpesvirus (KSHV/HHV-8) entry into the target cells. J. Virol., 80, 1167-1180.
63. Kurilla, M. G., Heineman, T., Davenport, L. C., Kieff, E., and Hutt-Fletcher, L. M. (1995). A novel Epstein-Barr virus glycoprotein gp150expressed from the BDLF3 open readingframe. Virology, 209, 108-121.
64. Lagunoff, M., Bechtel, J., Venetsanakos, E. et al. (2002). De novo infection and serial transmission of Kaposi's sarcoma-associated herpesvirus in cultured endothelial cells. J. Virol., 76(5), 2440-2448.
65. Lake, C. M. and Hutt-Fletcher, L. M. (2000). Epstein-Barr virus that lacks glycoprotein gN is impaired in assembly and infection. J. Virol., 74, 11162-11172.
66. Lake, C. M. and Hutt-Fletcher, L. M. (2004). The Epstein-Barr virus BFRF1 and BFLF2 proteins interact and coexpression alters their cellular localization. Virology, 320, 99-106.
67. Lambris, J. D., Ganu, V. S., Hirani, S., and Muller-Eberhard, H. J. (1985). Mapping of the C3d receptor (CR2) binding site and a neoantigenic site in the C3d domain of the third component of complement. Proc. Natl Acad. Sci. USA, 82, 4235-4239.
68. Lee, S. K. and Longnecker, R. (1997). The Epstein-Barr virus glyco-protein 110 carboxy-terminal tail domain is essential for lytic virus replication. J. Virol., 71, 4092-4097.
69. Lemon, S. M., Hutt, L. M., Shaw, J. E., Li, J.-L. H., and Pagano, J. S. (1977). Replication of EBV in epithelial cells during infectious mononucleosis. Nature, 268, 268-270.
70. Li, Q. X., Young, L. S., Niedobitek, G. et al. (1992). Epstein-Barr virus infection and replication ina human epithelial system. Nature, 356, 347-350.
71. Li, Q. X., Turk, S. M., and Hutt-Fletcher, L. M. (1995). The Epstein-Barr virus (EBV) BZLF2 gene product associates with the gH and gL homologs of EBV and carries an epitopecriticalto infec-tion of B cells but not of epithelial cells. J. Virol., 69, 3987-3994.
72. Li, Q. X., Spriggs, M. K., Kovats, S. et al. (1997). Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes. J. Virol., 71(6), 4657-4662.
73. Liao, W., Tang, Y., Kuo, Y. L., Liu, B. Y., Xu, C. J., and Giam, C. Z. (2003). Kaposi's sarcoma-associated herpesvirus/human her-pesvirus 8 transcriptional activator Rta is an oligomeric DNA-binding protein that interacts with tandem arrays of phased A/T-trinucleotide motifs. J. Virol., 77(17), 9399-9411.
74. Lo, P., Yu, X., Atanasov, I., Chandran, B., and Zhou, Z. H. (2003). Three-dimensional localization of pORF65 in Kaposi's sarcoma-associated herpesvirus capsid. J. Virol., 77(7), 4291-4297.
75. McShane, M. P. and Longnecker, R. (2004). Cell-surface expression of a mutated Epstein-Barr virus glycoprotein B allows fusion independent of other viral glycoproteins. Proc. Natl Acad. Sci. USA, 101, 17474-17479.
76. Mackett, M., Conway, M. J., Arrand, J. R., Haddad, R. S., and Hutt-Fletcher, L. M. (1990). Characterization and expression of a glycoprotein encoded by the Epstein-Barr virus BamHI 1 frag-ment. J. Virol., 64, 2545-2552.
77. Martin, D. R., Yuryev, A., Kalli, K. R., Fearon, D. T., and Ahearn, J. M. (1991). Determination of the structural basis for selective binding of Epstein-Barr virus to human complement receptor type 2. J. Exp. Med., 174, 1299-1311.
78. Martin, D. R., Marlowe, R. L., and Ahearn, J. M. (1994). Determina-tion of the role for CD21 during Epstein-Barr virus infection of B lymphoblastoid cells. J. Virol., 68, 4716-4726.
79. Miller, N. and Hutt-Fletcher, L. M. (1988). A monoclonal antibody to glycoprotein gp85 inhibits fusion but not attachment of Epstein-Barr virus. J. Virol., 62, 2366-2372.
80. Miller, N. and Hutt-Fletcher, L. M. (1992). Epstein-Barr virus enters B cells and epithelial cells by different routes. J. Virol., 66(6), 3409-3414.
81. Molesworth, S. J., Lake, C. M., Borza, C. M., Turk, S. M., and Hutt-Fletcher, L. M. (2000). Epstein-Barr virus gH is essential for penetration of B cell but also plays a role in attachment of virus to epithelial cells. J. Virol., 74, 6324-6332.
82. Moore, M. D., DiScipio, R. G., Cooper, N. R., and Nemerow, G. R. (1989). Hydrodynamic, electron microscopic and ligand bind-ing analysis of the Epstein-Barr virus/C3dg receptor (CR2). J. Biol. Chem., 34, 20576-20582.
83. Mori, Y., Akkapaiboon, P., Yang, X., and Yamanishi, K. (2003). The human herpesvirus 6 U100 gene product is the third compo-nent of the gH-gL glycoprotein complex on the viral envelope. J. Virol., 77, 2452-2458.
84. Moses, A. V., Fish, K. N., Ruhl, R. et al. (1999). Long-term infection and transformation of dermal microvascular endothelial cells by human herpesvirus 8. J. Virol., 73(8), 6892-6902.
85. Mullen, M. M., Haan, K. M., Longnecker, R., and Jardetzky, T. S. (2002). Structure of the Epstein-Barr virus gp42 protein bound to the MHC class II receptor HLA-DR1. Mol. Cell, 9, 375-385.
86. Naranatt, P. P., Akula, S. M., and Chandran, B. (2002). Characteriza-tion of gamma2-human herpesvirus-8 glycoproteins gH and gL. Arch. Virol., 147(7), 1349-1370.
87. Naranatt, P. P., Akula, S. M., Zien, C. A., Krishnan, H. H., and Chandran, B. (2003). Kaposi's sarcoma-associated herpesvirus induces the phosphatidylinositol 3-kinase-PKC-zeta-MEK-ERK signaling pathway in target cells early during infection: Implications for infectivity. J. Virol., 77(2), 1524-1539.
88. Naranatt, P. P., Krishnan, H. H., Smith, M. S., and Chandran, B. (2005). Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) modulates the microtubule dynamics via RhoA-GTP-Diaphenous-2 signaling and utilizes the dynein motors to deliver its DNA to the nucleus. J. Virol., 79, 1191-1206.
89. Neipel, F., Albrecht, J. C., and Fleckenstein, B. (1997). Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8: Determinants of its pathogenicity? J. Virol., 71(6), 4187-4192.
90. Nemerow, G. R. and Cooper, N. R. (1984). Early events in the infec-tion of human B lymphocytes by Epstein-Barr virus. Virology, 132, 186-198.
91. Nemerow, G. R., Wolfert, R., McNaughton, M., and Cooper, N. R.(1985). Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its rela-tionship to the C3d complement receptor (CR2). J. Virol., 55, 347-351.
92. Nemerow, G. R., Houghton, R. A., Moore, M. D., and Cooper, N. R. (1989). Identification of the epitope in the major enve-lope proteins of Epstein-Barr virus that mediates viral binding to the B lymphocyte EBV receptor (CR2). Cell, 56, 369-377.
93. Niedobitek, G., Hamilton-Dutoit, S., Herbst, H. et al. (1989). Iden-ti?cation of Epstein-Barr virus-infected cells in tonsils of acute infectious mononucleosis by in situ hybridization. Hum. Pathol., 20, 796-799.
94. Nolan, L. A. and Morgan, A. J. (1995). The Epstein-Barr virus open reading frame BDLF3 codes for a 100-150 kDa glycoprotein. J. Gen. Virol., 76, 1381-1392.
95. Oba, D. E. and Hutt-Fletcher, L. M. (1988). Induction of antibodies to the Epstein-Barr virus glycoprotein gp85 with a synthetic peptide corresponding to a sequence in the BXLF2 open read-ing frame. J. Virol., 62, 1108-1114.
96. Oda, T., Imai, S., Chiba, S., and Takada, K. (2000). Epstein-Barr virus lacking glycoprotein gp85 cannot infect B cells and epithelial cells. Virology, 276, 52-58.
97. Omerovic, J., Lev, L., and Longnecker, R. (2005). The amino ter-minus of Epstein-Barr virus glycoprotein gH is important for fusion with B cells and epithelial cells. J. Virol., 79, 12408-12415.
98. Paulsen, S. J., Rosenkilde, M. M., Eugen-Olsen, J., and Kledal, T. N. (2005). Epstein-Barr virus-encoded BILF1 is a constitutively active G protein-coupled receptor. J. Virol., 79, 536-546.
99. Pegtel, D. M., Middledorp, J., and Thorley-Lawson, D. A. (2004). Epstein-Barr virus infection in ex-vivo tonsil epithelial cultures of asymptomatic carriers. J. Virol., 78, 12613-12624.
100. Pertel, P. E. (2002). Human herpesvirus 8 glycoprotein B (gB), gH, and gL can mediate cell fusion. J. Virol., 76, 4390-4400.
101. Rappocciolo, G., Jenkins, F. L., Hensler, H. R. et al. (2006). DC-SIGN is a receptor for human herpesvirus 8 on dendritic cells and macrophages. J. Immunol., 176, 1741-1749.
102. Renne, R., Blackbourn, D., Whitby, D., Levy, J., and Ganem, D. (1998). Limited transmission of Kaposi's sarcoma-associated herpesvirus in cultured cells. J. Virol., 72(6), 5182-5188.
103. Ressing, M. E., van Leeuwen, D., Verreck, F. A. W. et al. (2005). Epstein-Barr virus gp42 is postranslationally modified to pro-duce s-gp42 that mediates class II immune evasion. J. Virol., 79, 841-852.
104. Rickinson, A. B. and Kieff, E. (2001). Epstein-Barr virus. In ?elds virology ed. D. M. Knipe, and P. M. Howley, Vol. 2, pp. 2575-2627.2 vols. Philadelphia: Lippincott, Williams and Wilkins.
105. Rivailler, P., Jiang, H., Cho, Y.-G., Quink, C., and Wang, F. (2002). Complete nucleotide sequence of the rhesus lymphocryptovirus: Genetic validation for an Epstein-Barr virus animal model. J. Virol., 76, 421-426.
106. Russo, J. J., Bohenzky, R. A., Chien, M. C. et al. (1996). Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc. Natl Acad. Sci. USA, 93, 14862-14867.
107. Sarid, R., Olsen, S. J., and Moore, P. S. (1999). Kaposi's sarcoma-associated herpesvirus: Epidemiology, virology, and molecular biology. Adv. Virus Res., 52, 139-232.
108. Sastry, S. K. and Burridge, K. (2000). Focal adhesions: A nexus for intracellular signaling and cytoskeletal dynamics. Exp. Cell Res., 261(1), 25-36.
109. Schulz, T. F., Sheldon, J., and Greensill, J. (2002). Kaposi's sar-coma associated herpesvirus (KSHV) or human herpesvirus 8 (HHV8). Virus Res., 82(1-2), 115-126.
110. Shannon-Rowe, C. D., Neuhierl, B., Baldwin, G., Rickinson, A. B., and Delecluse, H.-J. (2006). Resting B cells as a transfer vehicle for Epstein-Barr virus infection of epithelial cells. Proc. Natl Acad. Sci. USA, 103, 7065-7070
111. Sieczkarski, S. B. and Whittaker, G. R. (2002). Dissecting virus entry via endocytosis. J. Gen. Virol., 83(7), 1535-1545.
112. Sinclair, A. J. and Farrell, P. J. (1995). Host cell requirements for ef?cient infection of quiescent primary B lymphocytes by Epstein-Barr virus. J. Virol., 69, 5461-5468.
113. Sixbey, J. W. and Yao, Q.-Y. (1992). Immunoglobulin A-induced shift of Epstein-Barr virus tissue tropism. Science, 255, 1578-1580.
114. Sixbey, J. W., Nedrud, J. G., Raab-Traub, N., Hanes, R. A., and Pagano, J. S. (1984). Epstein-Barr virus replication in oropharyngeal epithelial cells. N. Engl. J. Med., 310, 1225-1230.
115. Spriggs, M. K., Armitage, R. J., Comeau, M. R. et al. (1996). The extra-cellular domain of the Epstein-Barr virus BZLF2 protein binds the HLA-DR beta chain and inhibits antigen presentation. J. Virol., 70, 5557-5563.
116. Sugano, N., Chen, W., Roberts, M. L., and Cooper, N. R. (1997). Epstein-Barr virus binding to CD21 activates the initial viral promoter via NFkB induction. J. Exp. Med., 186, 731-737.
117. Sun, R., Spain, T. A., Lin, S.-F., and Miller, G. (1997). Sp1 binds to the precise locus of end processing within the terminal repeats of Epstein-Barr virus DNA. J. Virol., 71, 6136-6143.
118. Tanner, J., Weis, J., Fearon, D., Whang, Y., and Kieff, E. (1987). Epstein-Barr virusgp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping and endocytosis. Cell, 50, 203-213.
119. Tanner, J., Whang, Y., Sample, J., Sears, A., and Keiff, E. (1988). Soluble gp350/220 and deletion mutant glycoproteins block Epstein-Barr virus adsorption to lymphocytes. J. Virol., 62, 4452-4464.
120. Tanner, J. E. and Tosato, G. (1992). Regulation of B-cell growth and immunoglobulin gene transcription by interleukin-6. Blood, 79, 452-459.
121. Telford, E. A., Watson, M. S., Aird, H. C., Perry, J., and Davison, A. J. (1995). The DNA sequence of equine herpesvirus 2. J. Mol. Biol., 249, 520-528.
122. Tomescu, C., Law, W. K., and Kedes, D. H. (2003). Surface downreg-ulation of major histocompatibility complex class I, PE-CAM, and ICAM-1 following de novo infection of endothelial cells with Kaposi's sarcoma-associated herpesvirus. J. Virol., 77(17), 9669-9684.
123. Trus, B. L., Heymann, J. B., Nealon, K. et al. (2001). Capsid struc-ture of Kaposi's sarcoma-associated herpesvirus, a gammaher-pesvirus, compared to those of an alphaherpesvirus, herpes simplex virus type 1, and a betaherpesvirus, cytomegalovirus. J. Virol., 75(6), 2879-2890.
124. Tugizov, S. M., Berline, J. W., and Palefsky, J. M. (2003). Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells. Nature Med., 9, 307-314.
125. Turk, S. M., Jiang, R., Chesnokova, L. S., and Hutt-Fletcher, L. M. (2006). Antibodiestogp350/220 enhancetheabilityof Epstein-Barr virus to infect epithelial cells. J. Virol., 80, 9628-9633
126. Venables, P. J. W., Teo, C. G., Baboonian, C., Grif?n, B. E., and Hughes, R. A. (1989). Persistence of Epstein-Barr virus in sali-vary gland biopsies from healthy individuals and patients with Sjogren's syndrome. Clin. Exp. Immunol., 75, 359-364.
127. Vieira, J., Ohearn, P., Kimball, L., Chandran, B., and Corey, L. (2001). Activation of Kaposi's sarcoma-associated her-pesvirus (human herpesvirus 8) lytic replication by human cytomegalovirus. J. Virol., 75(3), 1378-1386.
128. Virgin, H. W. I., Latreille, P., Wamsley, P. et al. (1997). Com-plete sequence and analysis of murine gammaherpesvirus 68. J. Virol., 71, 5894-5904.
129. Virji, M. (1996). Microbial utilization of human signalling molecules. Microbiology, 142(12), 3319-3336.
130. Wang, F. Z., Akula, S. M., Pramod, N. P., Zeng, L., and Chan-dran, B. (2001). Human herpesvirus 8 envelope glycoprotein K8.1A interaction with the target cells involves heparan sulfate. J. Virol., 75(16), 7517-7527.
131. Wang, F. Z., Akula, S. M., Sharma-Walia, N., Zeng, L., and Chan-dran, B. (2003). Human herpesvirus 8 envelope glycoprotein B mediates cell adhesion via its RGD sequence. J. Virol., 77(5), 3131-3147.
132. Wang, X. and Hutt-Fletcher, L. M. (1998). Epstein-Barr virus lacking glycoprotein gp42 can bind to B cells but is not able to infect. J. Virol., 72, 158-163.
133. Wang, X., Kenyon, W. J., Li, Q. X., Mullberg, J., and Hutt-Fletcher, L. M. (1998). Epstein-Barr virus uses different complexes of glycoproteins gH and gL to infect B lymphocytes and epithelial cells. J. Virol., 72, 5552-5558.
134. Weisman, H. F., Bartow, T., Leppo, M. K. et al. (1990). Soluble human complement receptor type 1: In vivo inhibitor of com-plement suppressing post-ischemic myocardial in?ammation and necrosis. Science, 249, 146-151.
135. Whittaker, G. R. (2003). Virus nuclear import. Adv. Drug Deliv. Rev., 55(6), 733-747.
136. Wu, L., Lo, P., Yu, X., Stoops, J. K., Forghani, B., and Zhou, Z. H. (2000). Three-dimensionalstructure of the human herpesvirus 8 capsid. J. Virol., 74, 9646-9654.
137. Wu, L., Borza, C. M., and Hutt-Fletcher, L. M. (2005). Mutations of Epstein-Barr virus gH that are differentially able to support fusion with B cells or epithelial cells. J. Virol., 79, 10923-10930.
138. Yaswen, L. R., Stephens, E. B., Davenport, L. C., and Hutt-Fletcher, L. M. (1993). Epstein-Barr virus glycoprotein gp85 associates with the BKRF2 gene product and is incompletely processed as a recombinant protein. Virology, 195, 387-396.
139. Young, L. S., Dawson, C. W., Brown, K. W., and Rickinson, A. B. (1989). Identification of a human epithelial cell surface protein sharing an epitope with the C3d/Epstein-Barr virus receptor molecule of B lymphocytes. Int. J. Cancer, 43, 786-794.
140. Zhu, F. X. and Yuan, Y. (2003). The ORF45 protein of Kaposi's sarcoma-associated herpesvirus is associated with puri?ed virions. J. Virol., 77(7), 4221-4230.
141. Zhu, L., Puri, V., and Chandran, B. (1999). Characterization of human herpesvirus-8 K8.1A/B glycoproteins by monoclonal antibodies. Virology, 262(1), 237-249.
142. Zhu, L., Wang, R., Sweat, A., Goldstein, E., Horvat, R., and Chan-dran, B. (1999). Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immuno?uo-rescence assays with HHV-8-infected BCBL-1 cells. Virology, 256(2), 381-392.